These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28886522)

  • 1. Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS - Increased sensitivity resulting from reduced non-specific binding.
    Blessborn D; Kaewkhao K; Song L; White NJ; Day NPJ; Tarning J
    J Pharm Biomed Anal; 2017 Nov; 146():214-219. PubMed ID: 28886522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma.
    Hodel EM; Zanolari B; Mercier T; Biollaz J; Keiser J; Olliaro P; Genton B; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):867-86. PubMed ID: 19249251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of the antimalarial drug pyronaridine in human whole blood.
    Schouten WM; Roseboom IC; Lucas L; Kabalu Tshiongo J; Muhindo Mavoko H; Kayentao K; Rosing H; Huitema ADR; Beijnen JH; Dorlo TPC
    J Pharm Biomed Anal; 2024 Aug; 245():116154. PubMed ID: 38657367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a liquid chromatography-mass spectrometry assay for the determination of pyronaridine in human blood for application to clinical pharmacokinetic studies.
    Naik H; Imming P; Schmidt MS; Murry DJ; Fleckenstein L
    J Pharm Biomed Anal; 2007 Sep; 45(1):112-119. PubMed ID: 17681448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of cationic anti-malaria agent methylene blue in different human biological matrices using cation exchange chromatography coupled to tandem mass spectrometry.
    Burhenne J; Riedel KD; Rengelshausen J; Meissner P; Müller O; Mikus G; Haefeli WE; Walter-Sack I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 863(2):273-82. PubMed ID: 18258499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a liquid chromatography-mass spectrometry assay for the determination of pyronaridine in human urine.
    Naik H; Wei SY; Schmidt MS; Murry DJ; Fleckenstein L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):80-7. PubMed ID: 17409032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a bioanalytical method by LC-MS/MS for the quantification of the LAFIS 10 - an antimalarial candidate - and its pharmacokinetics first evaluation.
    Laureano JV; Barreto F; Gnoatto S; Tasso L; Dalla Costa T; de Araujo BV
    Biomed Chromatogr; 2015 May; 29(5):664-70. PubMed ID: 25339180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
    Xue YJ; Akinsanya JB; Liu J; Unger SE
    Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast simultaneous quantitative analysis of FTY720 and its metabolite FTY720-P in human blood by on-line solid phase extraction coupled with liquid chromatography-tandem mass spectrometry.
    Emotte C; Deglave F; Heudi O; Picard F; Kretz O
    J Pharm Biomed Anal; 2012 Jan; 58():102-12. PubMed ID: 22018890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass balance and metabolism of the antimalarial pyronaridine in healthy volunteers.
    Morris CA; Dueker SR; Lohstroh PN; Wang LQ; Fang XP; Jung D; Lopez-Lazaro L; Baker M; Duparc S; Borghini-Fuhrer I; Pokorny R; Shin JS; Fleckenstein L
    Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):75-86. PubMed ID: 24590312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new and simple solid-phase extraction method for LC determination of pyronaridine in human plasma.
    Ramanathan S; Karupiah S; Nair NK; Olliaro PL; Navaratnam V; Wernsdorfer WH; Mansor SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):45-50. PubMed ID: 16046285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive and selective liquid chromatographic tandem mass spectrometric assay for simultaneous quantification of novel trioxane antimalarials in different biomatrices using sample-pooling approach for high throughput pharmacokinetic studies.
    Singh RP; Sabarinath S; Singh SK; Gupta RC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 864(1-2):52-60. PubMed ID: 18316253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved assay method for the determination of pyronaridine in plasma and whole blood by high-performance liquid chromatography for application to clinical pharmacokinetic studies.
    Chen YC; Fleckenstein L
    J Chromatogr B Biomed Sci Appl; 2001 Mar; 752(1):39-46. PubMed ID: 11254195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development and validation of an LC-MS/MS method for the determination of a new anti-malarial compound (TK900D) in human whole blood and its application to pharmacokinetic studies in mice.
    Abay ET; van der Westhuizen JH; Swart KJ; Gibhard L; Tukulula M; Chibale K; Wiesner L
    Malar J; 2014 Jan; 13():42. PubMed ID: 24484513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography-tandem mass spectrometry based method development and validation of S016-1271 (LR8P), a novel cationic antimicrobial peptide for its application to pharmacokinetic studies.
    Puttrevu SK; Laxman TS; Tripathi AK; Yadav AK; Verma SK; Mishra A; Pradhan R; Verma NK; Ghosh JK; Bhatta RS
    J Pharm Biomed Anal; 2019 May; 169():116-126. PubMed ID: 30851514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma.
    Huang L; Jayewardene AL; Li X; Marzan F; Lizak PS; Aweeka FT
    J Pharm Biomed Anal; 2009 Dec; 50(5):959-65. PubMed ID: 19646837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of simplified LC-MS/MS quantification of 25-hydroxyvitamin D using protein precipitation combined with on-line solid phase extraction (SPE).
    Thibeault D; Caron N; Djiana R; Kremer R; Blank D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():120-7. PubMed ID: 22265352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid resolution liquid chromatography-mass spectrometry determination of SAR97276 in monkey matrices. Pharmacokinetics in rhesus monkey infected by Plasmodium cynomolgi.
    Margout D; Bontemps N; Kocken CH; Vial HJ; Bressolle FM
    J Pharm Biomed Anal; 2009 Jul; 49(5):1266-71. PubMed ID: 19303732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of artemether and lumefantrine in human plasma: application for a pharmacokinetic study.
    César IC; Ribeiro JA; Teixeira Lde S; Bellorio KB; de Abreu FC; Moreira JM; Chellini PR; Pianetti GA
    J Pharm Biomed Anal; 2011 Jan; 54(1):114-20. PubMed ID: 20719459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.